Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Japanese and Dutch scientists design LTD4 and dual LTD4/H1 antagonists

Sep. 17, 1998

No Comments

Inspire enters into strategic partnership with Kissei

Sep. 16, 1998

No Comments

New Asta development candidate represents new type of PDE4 inhibitor

Sep. 15, 1998

No Comments

Antiasthma drug can be used safely in combination with anticonvulsants

Sep. 14, 1998

No Comments

Glaxo Wellcome receives first marketing approval for new asthma therapeutic

Sep. 14, 1998

No Comments

Two new LTD4 antagonists from Pfizer with promising profiles

Sep. 11, 1998

No Comments

Selective PDE4 inhibitors discovered at Jouveinal presented at ACS meeting

Sep. 11, 1998

No Comments

Texas Biotechnology announces positive data from phase IIa asthma study

Sep. 11, 1998

No Comments

Dimethoxy quinazoline derivative WHI-P180 inhibits mast cell mediator release

Sep. 11, 1998

No Comments

Schering-Plough prepares arylalkylamines as neurokinin antagonists

Sep. 10, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Respiratory
RSS

Japanese and Dutch scientists design LTD4 and dual LTD4/H1 antagonists

Inspire enters into strategic partnership with Kissei

New Asta development candidate represents new type of PDE4 inhibitor

Antiasthma drug can be used safely in combination with anticonvulsants

Glaxo Wellcome receives first marketing approval for new asthma therapeutic

Two new LTD4 antagonists from Pfizer with promising profiles

Selective PDE4 inhibitors discovered at Jouveinal presented at ACS meeting

Texas Biotechnology announces positive data from phase IIa asthma study

Dimethoxy quinazoline derivative WHI-P180 inhibits mast cell mediator release

Schering-Plough prepares arylalkylamines as neurokinin antagonists

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Respiratory RSS

Respiratory
RSS